ALDH7A1 and inclusion body myositis: 31P MRS‐based quantitative biomarkers of active muscle damage were elevated in IBM patients, reflecting possible anomalies in phospholipid membrane metabolism (elevated PDE/γATP and PME/γATP)17, 24, 28, 33, 34 or dysfunctional glycolysis (elevated PME/γATP).35